Inactive Instrument
Intellego Technologies AB Stock
Stocks
INT
SE0016075063
Biotechnology & Medical Research
| 1 day | +4.96% |
| Manager | Title | Age | Since |
|---|---|---|---|
Simon Marshall
CEO | Chief Executive Officer | - | - |
Henrik Resmark
DFI | Director of Finance/CFO | 57 | 2026-02-09 |
Laila Ostertag
CTO | Chief Tech/Sci/R&D Officer | - | 2021-08-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Carl Olsson
CHM | Chairman | 64 | 2026-02-22 |
| Director/Board Member | 63 | 2026-02-22 | |
Mats Geijer
BRD | Director/Board Member | 49 | 2026-02-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/16/25 | Buy | Chief Executive Officer | 3,000 | 0.0101% | ||
| 9/15/25 | Buy | Chief Executive Officer | 2,805 | 0.0095% | ||
| 9/9/25 | Buy | Chief Executive Officer | 363 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.96% | +13.54% | - | - | 167M | |
| +0.97% | -0.75% | +3.51% | +18.46% | 49.74B | |
| -0.30% | -2.88% | +429.29% | +496.95% | 44.98B | |
| +2.13% | +0.89% | +43.59% | +17.61% | 42.52B | |
| +0.87% | -3.73% | +8.96% | +73.17% | 40.78B | |
| -0.90% | -3.67% | +14.26% | +48.44% | 32.89B | |
| +2.71% | +6.82% | - | - | 17.09B | |
| +1.68% | -4.20% | +25.28% | +116.83% | 16.28B | |
| +1.70% | -0.05% | +18.53% | +28.50% | 14.4B | |
| +3.34% | -1.13% | +80.94% | +39.19% | 13.48B | |
| Average | +1.72% | -1.26% | +78.05% | +104.89% | 30.24B | |
| Weighted average by Cap. | +1.01% | -1.78% | +93.87% | +123.25% |
Employees
64
Calendar
